News

Results from Phase III Maintenance Trial of Antegren in Crohn’s Disease

Elan Corporation, plc and Biogen Idec announced that in a Phase III maintenance study, ANTEGREN® (natalizumab) maintained clinical response and remission rates throughout six months among patients with Crohn’s disease (CD) who had previously achieved clinical response. ...More

May 20, 2004

Posted in News, Disorders, Industry Issues

Pancreatic Cancer Blood Test Shows Promise

NEW ORLEANS — Pancreatic cancer kills swiftly and surely, and often goes undiagnosed until it’s far too late for doctors to provide the only cure: surgery. But new research being reported may give patients a better chance at early detection, firm diagnosis and, someday, ...More

May 20, 2004

Posted in News, Disorders, Industry Issues

Tumor Suppressor Gene Family May be Key to New Colon Cancer Drugs

In the hunt for new cancer drug targets, scientists from the Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute have discovered mutations in a family of genes linked to more than a quarter of colon cancers, as well as several other common cancers ...More

May 20, 2004

Posted in News, Disorders, Industry Issues, Procedures

New Target for Immunotherapy

Inflammatory bowel diseases (IBD) such as Crohn's disease have been thought to result from maladaptive immune responses to normal bacteria in the gut, but identifying the specific offending antigens among the 2 million present in the intestines has been a challenge to ...More

May 14, 2004

Posted in News, Disorders, Industry Issues

Protein Design Labs Announces Webcast on May 19 at 11 a.m. Eastern Time to Discuss Programs in Inflammatory Bowel Disease

FREMONT, Calif. -- Protein Design Labs, Inc. (PDL) announced that it will host a live webcast beginning at 11:00 a.m. Eastern time on May 19, 2004, to discuss clinical studies and development strategies for its inflammatory bowel disease programs, including results from a ...More

May 14, 2004

Posted in News, Disorders, Industry Issues, Procedures

One-Third of Health Services Workers Say They Do Not Feel Appreciated by Their Employers, Survey Finds

CHICAGO -- Thirty-four percent of health services workers say they feel their employers do not value their efforts on the job, according to a recent CareerBuilder.com survey. Four-in-ten health services workers also say they are dissatisfied with management’s ability to ...More

May 13, 2004

Posted in News, Industry Issues

Given Imaging Joins Crohn's and Colitis Foundation of America's President's Corporate Circle

ATLANTA -- Given Imaging has announced that the company has joined the Crohn’s and Colitis Foundation of America’s (CCFA) President’s Corporate Circle. Given Imaging and the CCFA will work together to broaden understanding and awareness of Capsule Endoscopy’s role in ...More

May 13, 2004

Posted in News, Disorders, Industry Issues, Procedures

Active Treatment Period of Sucampo's Randomized Withdrawal Study Mirrors Positive Results of Previous Pivotal Efficacy Studies for Constipation Treatment With SPI-0211

BETHESDA, Md. -- Sucampo Pharmaceuticals, Inc., a leader in functional fatty acid research and development, has announced that the active treatment period of its randomized withdrawal (RW) study for treating constipation with its proprietary agent SPI-0211 has duplicated ...More

May 13, 2004

Posted in News, Disorders, Industry Issues, Procedures

FDA Approves HalfLytely® for Colonoscopy Prep

BRAINTREE, Mass. -- Braintree Laboratories, Inc. has announced that the U.S. Food and Drug Administration has approved the HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (peg-3350, sodium chloride, sodium bicarbonate, potassium chloride for oral solution and bisacodyl ...More

May 13, 2004

Posted in News, Disorders, Industry Issues, Procedures

Seprafilm® Efficacy Data Presented at Surgical Meeting Shown to Reduce Incidences of Adhesive Small Bowel Obstruction Following Colorectal Surgery

CAMBRIDGE, Mass. -- Genzyme Corporation has announced clinical data were reported that show Seprafilm® Adhesion Barrier to be effective in reducing the incidence of adhesive small bowel obstruction following colorectal surgery. The data were presented at the annual meeting ...More

May 13, 2004

Posted in News, Disorders, Industry Issues, Procedures

DISINFECTION/STERILIZA...	DISPOSABLE PRODUCTS
ENDOSCOPE REPAIR	ENDOSCOPES
ENDOSCOPIC ACCESSORIES	More Options...

Video Snapshot

Most Recent Articles

Galleries

Most Popular Content

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail